Novavax will expand its phase 3 clinical trial of its covid-19 vaccine candidate to children ages 12 to 17.
Moderna Says Its COVID-19 Vaccine Is Safe and Effective in 12- to 17-Year-Olds
Cover Video STUDIO
On Tuesday, Moderna announced the results of their Phase 2 trial of the administration of their COVID-19 vaccine to children ages..
